CLEAR Outcomes Subanalysis
January 24, 2024 | Paul Ridker and C. Michael Gibson discuss whether residual inflammatory risk or residual cholesterol risk is a more effective predictor of CV events among patients treated with statins. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.